Trials / Completed
CompletedNCT01643421
Effect of a Program of Deep Inspiration Combined to Expiratory Positive Airway Pressure in Asthmatic
Effects of a Program of Deep Inspiration Combined to Expiratory Positive Airway in Quality of Life and Heart Rate Variability
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Federal University of Health Science of Porto Alegre · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the effects of a deep inspiration combined to expiratory positive airway pressure protocol on respiratory function, quality of life, exercise tolerance and heart rate variability in adults with severe asthma.
Detailed description
Asthma is associated with high morbidity and significant mortality. This disease has functional impact on activities of daily living (ADLs) and according to some studies in the United States and Europe, the percentage of asthmatics who have significant restrictions in their ADLs is quite significant. Asthma is characterized as a major public health problem, not only in Brazil but worldwide. Currently there are few studies reporting the effects of a domiciliary program of deep inspiration associated with positive expiratory pressure in the airways of asthmatics. This study aims to analyze the benefits of this program on lung function, quality of life and response to exercise.
Conditions
- Improvement of Functional Capacity.
- Improvement of Quality of Life.
- Improvement of Cardiovascular Autonomic Control.
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Deep inspiration and positive expiratory airway pressure | It was used a device the combines deep inspiration and positive expiratory airway pressure in asthmatic subjects, for 5 weeks, twice a day. |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2012-05-01
- Completion
- 2012-07-01
- First posted
- 2012-07-18
- Last updated
- 2014-08-11
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01643421. Inclusion in this directory is not an endorsement.